Streptococcus Group B antibody (Biotin)

Catalog No. ABIN954989

The Rabbit Polyclonal anti-Streptococcus Group B antibody is suitable to detect Streptococcus Group B in samples from Streptococcus. It has been validated for EIA and WB.

Quick Overview for Streptococcus Group B antibody (Biotin) (ABIN954989)

Target: Streptococcus Group B

Reactivity: Streptococcus

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Streptococcus Group B antibody is conjugated to Biotin

Application: Enzyme Immunoassay (EIA), Western Blotting (WB)

Product Details anti-Streptococcus Group B Antibody (Biotin)

Purification: Immunoaffinity chromatography.

Immunogen: Streptococci, group B

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL (OD280 nm, E0.1% = 1.4)

Buffer: 0.01 M PBS, pH 7.2, containing 0.09 % Sodium azide as preservative.

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing. Dilute only prior to immediate use. Freezing alkaline phosphatase conjugates will result in a substantial loss of enzymatic activity.

Storage: 4 °C

Storage Comment: Store the antibody undiluted at 2-8 °C before opening. DO NOT FREEZE!

Target Details for Streptococcus Group B

Target: Streptococcus Group B

Target Type: Bacteria

Background: Streptococci form part of the normal human flora that resides on the skin, and can also colonise the respiratory, gastrointestinal, and genitourinary tracts. Streptococci can cause a range of diseases, from the less serious but common sore throats and skin infections to life threatening conditions such as necrotising fasciitis. Different streptococcal species are involved in human disease, broadly categorised as pus forming or pyogenic streptococci, non pus forming or non pyogenic streptococci, and Streptococcus pneumoniae. Streptococci are classified into Lancefield serotypes by their cell wall polysaccharide antigens. Group A are primarily pathogens. Group B streptococci (including Streptococcus agalactiae) are the leading bacterial causes of human neonatal illness and death causing opportunistic invasive disease in pregnant women such as preterm labour, membrane rupture and urinary tract infections and sepsis and meningitis in newborns.